Invention Grant
US08334271B2 Use of VEGF in the treatment of retarded fetal growth in pregnancy
有权
在妊娠期使用VEGF治疗延迟胎儿生长
- Patent Title: Use of VEGF in the treatment of retarded fetal growth in pregnancy
- Patent Title (中): 在妊娠期使用VEGF治疗延迟胎儿生长
-
Application No.: US12522640Application Date: 2008-02-22
-
Publication No.: US08334271B2Publication Date: 2012-12-18
- Inventor: John Francis Martin , Charles Henry Rodeck
- Applicant: John Francis Martin , Charles Henry Rodeck
- Applicant Address: GB London
- Assignee: Ark Therapeutics, Ltd.
- Current Assignee: Ark Therapeutics, Ltd.
- Current Assignee Address: GB London
- Agency: Pharmaceutical Patent Attorneys, LLC
- Priority: GB0703683.3 20070226
- International Application: PCT/GB2008/000613 WO 20080222
- International Announcement: WO2008/104747 WO 20080904
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/04 ; C12N15/00
Abstract:
An agonist of the VEGF receptor is useful in the treatment of a disease associated with retarded fetal growth, such as intra-uterine growth retardation. The VEGF agonist may be a VEGF peptide or a gene construct encoding or expressing such a peptide.
Public/Granted literature
- US20100249015A1 Use of VEGF in the Treatment of Retarded Fetal Growth in Pregnancy Public/Granted day:2010-09-30
Information query
